It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARAY’s FA Score shows that 0 FA rating(s) are green whileVNRX’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARAY’s TA Score shows that 5 TA indicator(s) are bullish while VNRX’s TA Score has 2 bullish TA indicator(s).
ARAY (@Medical/Nursing Services) experienced а -4.61% price change this week, while VNRX (@Medical/Nursing Services) price change was -0.04% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.38%. For the same industry, the average monthly price growth was -2.45%, and the average quarterly price growth was +13.17%.
ARAY is expected to report earnings on May 06, 2026.
VNRX is expected to report earnings on Mar 31, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ARAY | VNRX | ARAY / VNRX | |
| Capitalization | 85.8M | 31.9M | 269% |
| EBITDA | 7.67M | -20.26M | -38% |
| Gain YTD | -8.246 | 1.682 | -490% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 451M | 1.47M | 30,639% |
| Total Cash | 63.3M | 199K | 31,809% |
| Total Debt | 179M | 11.3M | 1,584% |
ARAY | VNRX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 100 | |
PRICE GROWTH RATING 1..100 | 91 | 88 | |
P/E GROWTH RATING 1..100 | 47 | 100 | |
SEASONALITY SCORE 1..100 | 85 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VNRX's Valuation (56) in the Medical Or Nursing Services industry is in the same range as ARAY (84) in the Medical Specialties industry. This means that VNRX’s stock grew similarly to ARAY’s over the last 12 months.
VNRX's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that VNRX’s stock grew similarly to ARAY’s over the last 12 months.
ARAY's SMR Rating (97) in the Medical Specialties industry is in the same range as VNRX (100) in the Medical Or Nursing Services industry. This means that ARAY’s stock grew similarly to VNRX’s over the last 12 months.
VNRX's Price Growth Rating (88) in the Medical Or Nursing Services industry is in the same range as ARAY (91) in the Medical Specialties industry. This means that VNRX’s stock grew similarly to ARAY’s over the last 12 months.
ARAY's P/E Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for VNRX (100) in the Medical Or Nursing Services industry. This means that ARAY’s stock grew somewhat faster than VNRX’s over the last 12 months.
| ARAY | VNRX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 89% | 2 days ago 89% |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 85% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| Advances ODDS (%) | 7 days ago 73% | 17 days ago 75% |
| Declines ODDS (%) | 3 days ago 81% | 8 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 84% |
| Aroon ODDS (%) | N/A | 2 days ago 90% |
A.I.dvisor indicates that over the last year, ARAY has been closely correlated with CLPT. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARAY jumps, then CLPT could also see price increases.
| Ticker / NAME | Correlation To ARAY | 1D Price Change % | ||
|---|---|---|---|---|
| ARAY | 100% | +0.65% | ||
| CLPT - ARAY | 66% Closely correlated | -4.52% | ||
| ITGR - ARAY | 64% Loosely correlated | -0.60% | ||
| NNOX - ARAY | 60% Loosely correlated | -5.10% | ||
| TELA - ARAY | 52% Loosely correlated | -3.64% | ||
| NXL - ARAY | 52% Loosely correlated | -0.16% | ||
More | ||||
A.I.dvisor indicates that over the last year, VNRX has been loosely correlated with ARAY. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VNRX jumps, then ARAY could also see price increases.
| Ticker / NAME | Correlation To VNRX | 1D Price Change % | ||
|---|---|---|---|---|
| VNRX | 100% | -4.55% | ||
| ARAY - VNRX | 57% Loosely correlated | +0.65% | ||
| RBOT - VNRX | 50% Loosely correlated | -5.80% | ||
| CLPT - VNRX | 43% Loosely correlated | -4.52% | ||
| NNOX - VNRX | 42% Loosely correlated | -5.10% | ||
| PODD - VNRX | 40% Loosely correlated | +0.01% | ||
More | ||||